Latest News and Press Releases
Want to stay updated on the latest news?
-
12. november 2024 Pressemeddelelse BioPorto A/S inviterer til webcast KØBENHAVN, DANMARK og BOSTON, MA, USA, 12. november, 2024 (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto eller Selskabet)...
-
November 12, 2024 News release BioPorto A/S to Host Third Quarter 2024 Earnings Webcast COPENHAGEN, DENMARK and BOSTON, MA, USA, November 12, 2024 (GLOBE NEWSWIRE) – BioPorto A/S...
-
8 November 2024 New Release BioPorto Sponsors Exhibits to Showcase Launch of ProNephro AKI in the U.S. and Ongoing Marketing of The NGAL Test to Clinicians at Major Healthcare...
-
4 November 2024Announcement no. 21 Grant of Warrants COPENHAGEN, DENMARK and BOSTON, MA, USA, November 4, 2024 (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (“BioPorto” or the...
-
29. oktober 2024Selskabsmeddelelse nr. 20 Første patient indrulleret - BioPorto har påbegyndt indrullering til det amerikanske studie vedrørende ProNephro AKI (NGAL)™ til voksen brug ved...
-
October 29, 2024Announcement no. 20 First Patient In - BioPorto Initiates Patient Enrollment for US Study of ProNephro AKI (NGAL)™ for Adult Use at Massachusetts General Hospital COPENHAGEN,...
-
28. oktober 2024Selskabsmeddelelse nr. 19 BioPorto indgår globalt distributionspartnerskab med Beckman Coulter om NGAL Tests til akut nyreskade KØBENHAVN, Danmark og BOSTON, MA, USA, 28. oktober,...
-
28 October 2024Announcement no. 19 BioPorto Enters Global Distribution Partnership with Beckman Coulter for Acute Kidney Injury NGAL Tests COPENHAGEN, DENMARK and BOSTON, MA, USA,...
-
23. oktober 2024 Pressemeddelelse BioPorto præsenterer den FDA-godkendte ProNephro AKI (NGAL) test på ASN Kidney Week 2024 Conference KØBENHAVN, Danmark og BOSTON, MA, USA, 23. oktober, 2024 (GLOBE...
-
October 23, 2024 News Release BioPorto Presenting FDA-cleared ProNephro AKI (NGAL) at ASN Kidney Week 2024 Conference COPENHAGEN, Denmark and BOSTON, MA, USA, October 23, 2024,...